This report segments the regenerative medicine market by product (cell therapy and scaffold) and by application (dermatology, musculoskeletal, ocular, and cardiovascular). The report presents the vendor landscape and a corresponding detailed analysis of the key vendors, which include Acelity, Mesoblast, Organogenesis, Reprocell, and Stryker.
Technavio has released its new market research report, regenerative medicine market in the US, which is expected to generate revenues of $7 billion between 2016 and 2020. Regenerative medicine is an emerging field of treatment that helps in producing new cells to substitute malfunctioning or injured cells as a vehicle to treat disease and injury. Rising incidences of chronic diseases in US is a major factor propelling the demand for regenerative medicines.
“One of the latest trends gaining grounds in this market is the growing demand for tissue-engineered and stem cell products for the treatment of various diseases. The potential of these medicines in regenerating diseased organs is one of the major factors that drives the market in the US. The stem cells application and advancements in nanotechnology will further drive the progress in this market,” says Brahadeesh Chandrasekaran, Lead Analyst, Healthcare & Lifesciences, Technavio Research.
Dermatology is the dominant user of regenerative medicines, accounting for 51% of the overall market share. Dermatology includes the treatment of burns and chronic wounds that requires a quick response, and skin grafting is essential in many cases. Factors such as the increase in obesity and diabetes, growing elderly population, and an increase in life expectancy are some of the causes contributing to the growth of the dermatology market.
The key vendors in the regenerative medicine market in the US include Acelity, Mesoblast, Organogenesis, Reprocell, and Stryker. This market is highly competitive and fragmented because of the presence of several established vendors and this competitive environment is expected to intensify with advances in R&D and technological innovations. International players are likely to acquire regional or local players to enhance their products and expand their market share during the forecast period.
A more detailed analysis is available in the Technavio report, Regenerative Medicine Market in the US 2016-2020.
We can customize this reports by other regions and specific segments upon request.
Other related reports:
- Global Stem Cell Banking Market 2015-2019
- Global Human Insulin Market 2015-2019
- Global Cell Counting Market 2015-2019
- Global Tissue Diagnostics Market 2014-2018
- Global Orthopedic Soft Tissue Repair Devices Market 2014-2018
Further readings:
